Teraplast Statistics

Total Valuation

Teraplast has a market cap or net worth of RON 1.16 billion. The enterprise value is 1.51 billion.

Market Cap	1.16B
Enterprise Value	1.51B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Teraplast has 2.40 billion shares outstanding. The number of shares has increased by 10.20% in one year.

Current Share Class	2.40B
Shares Outstanding	2.40B
Shares Change (YoY)	+10.20%
Shares Change (QoQ)	+7.59%
Owned by Insiders (%)	42.61%
Owned by Institutions (%)	24.66%
Float	1.16B

Valuation Ratios

PE Ratio	n/a
Forward PE	48.25
PS Ratio	1.18
PB Ratio	2.65
P/TBV Ratio	3.25
P/FCF Ratio	n/a
P/OCF Ratio	273.46
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.73, with an EV/FCF ratio of -29.17.

EV / Earnings	-94.61
EV / Sales	1.55
EV / EBITDA	22.73
EV / EBIT	149.79
EV / FCF	-29.17

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.79.

Current Ratio	1.22
Quick Ratio	0.66
Debt / Equity	0.79
Debt / EBITDA	5.17
Debt / FCF	-6.64
Interest Coverage	0.55

Financial Efficiency

Return on equity (ROE) is -4.20% and return on invested capital (ROIC) is 0.88%.

Return on Equity (ROE)	-4.20%
Return on Assets (ROA)	0.64%
Return on Invested Capital (ROIC)	0.88%
Return on Capital Employed (ROCE)	1.43%
Revenue Per Employee	893,739
Profits Per Employee	-14,604
Employee Count	1,127
Asset Turnover	0.99
Inventory Turnover	3.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.05% in the last 52 weeks. The beta is 0.66, so Teraplast's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-12.05%
50-Day Moving Average	0.40
200-Day Moving Average	0.44
Relative Strength Index (RSI)	68.41
Average Volume (20 Days)	1,618,027

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Teraplast had revenue of RON 979.54 million and -16.01 million in losses. Loss per share was -0.01.

Revenue	979.54M
Gross Profit	349.69M
Operating Income	10.11M
Pretax Income	-11.41M
Net Income	-16.01M
EBITDA	60.77M
EBIT	10.11M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 22.91 million in cash and 344.61 million in debt, giving a net cash position of -321.70 million or -0.13 per share.

Cash & Cash Equivalents	22.91M
Total Debt	344.61M
Net Cash	-321.70M
Net Cash Per Share	-0.13
Equity (Book Value)	437.18M
Book Value Per Share	0.17
Working Capital	87.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.24 million and capital expenditures -56.15 million, giving a free cash flow of -51.91 million.

Operating Cash Flow	4.24M
Capital Expenditures	-56.15M
Free Cash Flow	-51.91M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 35.70%, with operating and profit margins of 1.03% and -1.63%.

Gross Margin	35.70%
Operating Margin	1.03%
Pretax Margin	-1.16%
Profit Margin	-1.63%
EBITDA Margin	6.20%
EBIT Margin	1.03%
FCF Margin	n/a

Dividends & Yields

Teraplast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.20%
Shareholder Yield	n/a
Earnings Yield	-1.38%
FCF Yield	-4.48%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 28, 2021. It was a forward split with a ratio of 1.25.

Last Split Date	Sep 28, 2021
Split Type	Forward
Split Ratio	1.25

Scores

Teraplast has an Altman Z-Score of 2.06. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.06
Piotroski F-Score	n/a